Novavax (NVAX) Announces AdCom Recommends Emergency Use Authorization of its COVID-19 Vaccine for People Aged 18 Years and Older

Go back to Novavax (NVAX) Announces AdCom Recommends Emergency Use Authorization of its COVID-19 Vaccine for People Aged 18 Years and Older

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

June 7, 2022 5:08 PM EDT

Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the U.S.

GAITHERSBURG, Md., June 7,... More